Entresto

IRA negotiations slash Medicare prices for Big Pharma blockbusters by up to 79%
Fierce Pharma
Thu, 08/15/24 - 11:55 am
Medicare
drug pricing
Inflation Reduction Act
JNJ
Xarelto
Imbruvica
Stelara
Bristol Myers Squibb
Eliquis
Eli Lilly
Jardiance
Merck
Januvia
Amgen
Enbrel
AstraZeneca
Farxiga
Novo Nordisk
Fiasp
Novartis
Entresto
Novartis loses initial bid to block generic of best-selling heart drug
Reuters
Mon, 08/12/24 - 05:57 pm
Novartis
legal
MSN Pharmaceuticals
Entresto
heart failure
generics
Novartis files suit against IRA after blockbuster Entresto makes CMS' price negotiations list
Fierce Pharma
Tue, 09/5/23 - 08:54 pm
Novartis
legal
Inflation Reduction Act
CMS
drug pricing
Entresto
Novartis hits back at Entresto selection on Medicare list
Pharmaphorum
Wed, 08/30/23 - 10:01 am
Novartis
Entresto
drug pricing
Medicare
The Biopharma Patent Cliff: 9 Drugs Losing Exclusivity by the End of 2023
BioSpace
Wed, 08/23/23 - 11:11 am
patent cliff
patents
Takeda
Vyvanse
Pfizer
Eraxis
JNJ
Stelara
Merck
Isentress
Eiger Pharmaceuticals
Zokinvy
Astellas
Myrbetriq
Novartis
Entresto
Amgen
Otzela
Novartis to appeal district court ruling on heart drug patent
BioPharma Dive
Mon, 07/10/23 - 09:28 pm
Novartis
Entresto
patents
legal
Novartis' Entresto infringes on university patents, lawsuit claims
Endpoints
Wed, 08/31/22 - 10:29 am
Novartis
Entresto
legal
patents
Novartis petitions FDA to block 18 generic competitors for its megablockbuster heart drug until 2024
Endpoints
Mon, 12/6/21 - 10:52 am
Novartis
generics
Entresto
ACC 2021: Novartis looks for silver linings in Entrestro’s narrow loss to an ACE inhibitor in heart attack patients
Fierce Pharma
Sat, 05/15/21 - 11:00 pm
ACC
Novartis
Entresto
heart failure
Novartis’ blockbuster heart med Entresto snags FDA approval in larger patient group
Fierce Pharma
Tue, 02/16/21 - 11:40 pm
Novartis
Entresto
heart failure
labeling
FDA
Novartis' heart failure med Entresto wins FDA panel backing for bigger patient group—but just how much bigger?
Fierce Pharma
Wed, 12/16/20 - 11:35 am
Novartis
Entresto
heart failure
heart failure with preserved ejection fraction
ESC: Novartis' Entresto racks up a heart failure study win—but it's a mixed one
Fierce Pharma
Mon, 08/31/20 - 10:20 am
Novartis
Entresto
ESC
heart failure
Novartis' Entresto gains steam with cardiologists despite stinging heart failure trial flop
Fierce Pharma
Wed, 07/15/20 - 11:17 am
Novartis
Entresto
heart failure
cardiologists
AHA: Novartis hoping for second go at broader use with 'profound' Entresto subdata
Fierce Pharma
Sun, 11/17/19 - 08:38 pm
Novartis
AHA
Entresto
ESC: Novartis looks for the bright side in flopped Entresto heart failure study
Fierce Pharma
Mon, 09/2/19 - 12:19 pm
Novartis
heart failure
Entresto
clinical trials
ESC
European Society of Cardiology
5 Reasons Novartis Shareholders Aren't Shaken
Yahoo/Motley Fool
Mon, 08/12/19 - 10:32 am
Novartis
Zolgensma
FDA
shareholders
Entresto
Novartis heart drug fails trial, curbing growth prospects
Yahoo/Reuters
Mon, 07/29/19 - 09:26 am
Novartis
heart failure
Entresto
clinical trials
American College of Cardiology Conference Roundup - day 1
CP Wire
Sun, 03/17/19 - 01:25 pm
American College of Cardiology
Novartis
Entresto
heart failure
Edwards Lifesciences
Apple
TAVR
wearables
clinical trials
Apple Watch
atrial fibrillation
American College of Cardiology Conference Roundup - day 1
Sun, 03/17/19 - 01:24 pm
American College of Cardiology
Novartis
Entresto
heart failure
Edwards Lifesciences
Apple
TAVR
wearables
clinical trials
Apple Watch
atrial fibrillation
Novartis builds its blockbuster case for Entresto, beating out a cheap ACE inhibitor in a head-to-head study
Endpoints
Mon, 11/12/18 - 11:49 pm
Novartis
Entresto

Pages